Accordingly, survivin-ΔEx3 was differentially expressed in breast tumors with high proliferative index, as determined by Ki-67 immunoreactivity (>15% Ki-67+ cells; Figure 4A, P = 0.03). Here, MKI67 is linked to breast neoplasm.